Results 71 to 80 of about 8,176 (156)

Eradication of Helicobacter pylori: are rifaximin-based regimens effective? [PDF]

, 2006
Rifaximin is a non-absorbed semisynthetic rifamycin derivative with a broad spectrum of antibacterial activity including Gram-positive and Gram-negative bacteria, both aerobes and anaerobes.
Gasbarrini, Antonio, Gasbarrini, Giovanni Battista   +1 more
core  

NMR studies of a new class of rifaximin derived molecules: Rifaximin OR (Open Ring) [PDF]

, 1996
The electrolytic selective reduction of the aliphatic chain of rifaximin gave a new open-ring ansamycin structure which has been characterized by NMR ...
Bonechi, Claudia, Donati, Alessandro, Marchettini, Nadia, Corti, Piero, Rossi, Claudio, Corbini, Gianfranco   +5 more
core  

<i>In vitro</i> study of ethanol production, ethanol tolerance, and antimicrobial susceptibility of gut microbes associated with liver diseases. [PDF]

Gut Microbes Rep
Idrissa Abdoulaye A, Mbaye B, Magdy Wasfy R, Carmarans L, Beye M, Andrieu C, Bakour S, Hamieh A, Armstrong N, Borentain P, Bittar F, Ranque S, Rolain JM, Dubourg G, Lagier JC, Tidjani Alou M, Gerolami R, Million M.   +17 more
europepmc   +1 more source

Relationship between small intestinal bacterial overgrowth and irritable bowel syndrome and the efficacy of rifaximin intervention: a systematic review and meta-analysis. [PDF]

Front Microbiol
Lu H.
europepmc   +1 more source

Rifaximin-Induced Rhabdomyolysis. [PDF]

Cureus
Acheampong S, Udoyeh C, Darko P, Omeludike EK.   +3 more
europepmc   +1 more source

Secondary Prophylaxis of Hepatic encephalopathy in Liver cirrhosis: Rifixamine plus Probiotics vs. Rifixamine alone. [PDF]

Pak J Med Sci
Shahzad K, Sarwar S, Saeed S, Umer A.
europepmc   +1 more source

Rifaximin Use Is Associated With Prognosis and Recurrence Patterns in Spontaneous Bacterial Peritonitis: Exploratory Insights Into the Oral-Gut-Hepatic Axis. [PDF]

JGH Open
Uchida Y, Soma N, Yamada S, Tsuji S, Ando S, Sugawara K, Nakao M, Nakayama N, Imai Y, Mizuno S, Mochida S.   +10 more
europepmc   +1 more source

Understanding Hepatic Encephalopathy: Patient Knowledge, Adherence, and Barriers to Care in Cirrhosis. [PDF]

Cureus
Albusta N, Ali A, Alrahma H.
europepmc   +1 more source

[Rifaximin].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2004
M, Gobernado, J, Ponce
openaire   +1 more source

Synergistic effect of the rifaximin-berberine combination against <i>Klebsiella pneumoniae</i>: RfaH targeting supported by MD simulation. [PDF]

Biomol Biomed
Ashraf A, Khan MA, Choudhury A, Kumari S, Alotaibi BS, Noor S, Adnan M, Hassan MI.   +7 more
europepmc   +1 more source